Optimized Size Exclusion Chromatography Reveals Extracellular Vesicles as Key Carriers of ALK Translocations in Non-Small Cell Lung Cancer

Strategic Insights -

Researchers at the Spanish National Centre for Biotechnology (CNB-CSIC) have made a groundbreaking discovery in the field of oncology by identifying extracellular vesicles (EVs) as the primary carriers of fusion RNA in non-small cell lung cancer (NSCLC) patients. This finding has significant implications for the diagnosis and treatment of NSCLC, a leading cause of cancer deaths worldwide.

The study, led by Estela Sanchez-Herrero, employed optimized size-exclusion chromatography (SEC) to separate EVs, lipoproteins (LPPs), and protein-enriched fractions from NSCLC cell lines and plasma samples from patients with translocations. Digital PCR (dPCR) results indicated that fusions were more prevalent in tetraspanin-enriched SEC fractions from NSCLC cell lines, suggesting that EVs serve as the primary carrier for fusion RNA.

Key Takeaways:

  • The study highlights the potential of EV-associated RNA as a non-invasive diagnostic approach for detecting fusion variants in plasma samples from NSCLC patients.
  • Extracellular vesicles (EVs) are revealed as the primary carriers of fusion RNA in NSCLC patients.
  • Digital PCR results indicate that fusions are more prevalent in tetraspanin-enriched SEC fractions from NSCLC cell lines.
  • The study provides evidence that EVs serve as the primary carrier for fusion RNA, offering a non-invasive diagnostic approach with significant clinical implications.
  • The research has been peer-reviewed and published in the journal Extracellular Vesicles and Circulating Nucleic Acids.
  • The study was conducted by a team of researchers led by Estela Sanchez-Herrero from the Spanish National Centre for Biotechnology (CNB-CSIC).

Statistics:

  • The circulating number of copies of the transcript was found to be below 5 copies/mL.
  • The study employed optimized size-exclusion chromatography (SEC) to separate EVs, LPPs, and protein-enriched fractions from NSCLC cell lines and plasma samples from patients with translocations.
  • Digital PCR results indicated that fusions were more prevalent in tetraspanin-enriched SEC fractions from NSCLC cell lines.

Sources:

  • Estela Sanchez-Herrero et al., Optimized size exclusion chromatography demonstrates that extracellular vesicles are the key RNA carriers of ALK translocations in non-small cell lung cancer cell line secretome and patient plasma. Extracellular Vesicles and Circulating Nucleic Acids, 2025;6(2):310-23.
  • NewsRx. Findings from Estela Sanchez-Herrero and Co-Researchers Provides New Data on Non-Small Cell Lung Cancer (Optimized size exclusion chromatography demonstrates that extracellular vesicles are the key RNA carriers of ALK translocations in ...). Cancer Weekly. September 16, 2025; p 544.